Med Ad News spoke with James Talerico and Nadine Leonard, co-presidents of Heartbeat, and Michelle Edwards, the agency’s VP of human resources, about why the agency wrote its letter about improving diversity and inclusivity, where Heartbeat will be in the next few years in its D&I goals, and how Edwards has worked to make an […]
If you are not happy with the results below please do another search
50 search results for:
As the United States continues to grapple with race issues in the wake of the death of George Floyd, the leaders of Heartbeat have issued their own call for more diversity and inclusion within the healthcare advertising industry, and Heartbeat in particular. The agency recently issued a letter, “Heartbeat’s Commitment to Diversity,” that elaborates on […]
As the world is eagerly awaiting news of an effective and safe vaccine against Covid-19, several companies are moving ahead testing therapeutic antibodies against the disease.
A roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, the illness caused by the virus.
Published research in the peer-reviewed scientific journal Cell outlines a way to make even immunotherapy-resistant cancers treatable.
A study published in the Journal of the American Medical Association shows that a new blood test may be helpful for detecting Alzheimer’s disease as early as 20 years before the onset of cognitive impairment.
A recent report in the New England Journal of Medicine reveals that the racial and ethnic minority groups most negatively impacted by Covid-19 are also the least represented in these clinical studies to develop vaccines and therapeutics aimed at the disease.
U.K.-based Celleron Therapeutics signed a licensing agreement with Swiss pharma giant Roche for the worldwide rights to the cancer drug emactuzumab, a monoclonal antibody directed against colony-stimulating factor 1 (CSF-1R) expressed on macrophages.
Vaping may be associated with a five to seven times increased risk of Covid-19 among U.S. teenagers and young adults, a published study suggests.
San Diego-based Ligand Pharmaceuticals is acquiring San Diego-based Pfenex for a total deal transaction of up to $516 million.